PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE OXALIPLATIN) AS ADJUVANT TREATMENT IN STAGE III COLON CANCER UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71988-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)71988-X/fulltext
Title :
PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE OXALIPLATIN) AS ADJUVANT TREATMENT IN STAGE III COLON CANCER UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71988-X&doi=10.1016/S1098-3015(11)71988-X
First page :
A268
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
145